Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Sales in the cooperation business increased by 36% to EUR 12.6 million in the financial year (2023: EUR 9.3 million). The agreement concluded with Novartis in April 2024 for the two asthma products ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

About DSD Pharma DSD Pharma is a well-established pharmaceutical distribution company operating in Austria, Germany, and Switzerland, specializing in the distribution of cutting-edge healthcare ...

MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...

Purdue Pharma has filed a new bankruptcy plan to settle thousands of lawsuits over the toll of the opioid painkiller ...

One of three people charged in connection with the theft of large quantities of prescription medication from a Glasgow ...

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq ...